Sources say drug maker plans $60B acquisition of rival Wyeth
                                
                                
                                    (Newser) -
                                    Pfizer is seeking to create a Big Pharma behemoth with the acquisition of rival Wyeth, insiders tell the Wall Street Journal. The deal, expected to be worth around $60 billion, would make Pfizer—already the world's biggest drug company—big enough to redraw the map of the industry, although sources...